Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Krista Dariotis, PharmD Candidate
Advertisement
Articles by Krista Dariotis, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 ‘Is Not Done With Us’: Pharmacist Urges Continued Vaccination Ahead of Seasonal Peaks
2
Tarlatamab and Next-Generation Targeted Agents Headline ESMO 2026 Lung Cancer Data
3
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Ribociclib Survival Data Anchor a Sobering ESMO 2026 for Breast Cancer
5